Cholecystokinin-dopamine intearctions

Research output: Contribution to journalArticle

240 Citations (Scopus)

Abstract

Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory actions of dopamine, in the mesolimbic pathway. Nonpeptide antagonists selective for the CCKA and CCKB receptors have recently been developed, and provide long-awaited tools to test hypotheses about the role of endogenous CCK as a modulator of dopaminergic function, and the potential of CCK-based drugs as treatments for neuropsychiatric disorders.

Original languageEnglish (US)
Pages (from-to)232-236
Number of pages5
JournalTrends in Pharmacological Sciences
Volume12
Issue numberC
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Cholecystokinin
Dopamine
Substantia Nigra
Primates
Modulators
Neurons
Rodentia
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Cholecystokinin-dopamine intearctions. / Crawley, Jacqueline.

In: Trends in Pharmacological Sciences, Vol. 12, No. C, 1991, p. 232-236.

Research output: Contribution to journalArticle

@article{c9f68c9fd48d4695bf4f728d1b44eea7,
title = "Cholecystokinin-dopamine intearctions",
abstract = "Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory actions of dopamine, in the mesolimbic pathway. Nonpeptide antagonists selective for the CCKA and CCKB receptors have recently been developed, and provide long-awaited tools to test hypotheses about the role of endogenous CCK as a modulator of dopaminergic function, and the potential of CCK-based drugs as treatments for neuropsychiatric disorders.",
author = "Jacqueline Crawley",
year = "1991",
doi = "10.1016/0165-6147(91)90558-A",
language = "English (US)",
volume = "12",
pages = "232--236",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "C",

}

TY - JOUR

T1 - Cholecystokinin-dopamine intearctions

AU - Crawley, Jacqueline

PY - 1991

Y1 - 1991

N2 - Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory actions of dopamine, in the mesolimbic pathway. Nonpeptide antagonists selective for the CCKA and CCKB receptors have recently been developed, and provide long-awaited tools to test hypotheses about the role of endogenous CCK as a modulator of dopaminergic function, and the potential of CCK-based drugs as treatments for neuropsychiatric disorders.

AB - Cholecystokinin (CCK) coexists with dopamine in a large proportion of the ventral tegmental and substantia nigra neurons in rodents primates. In this review Jacki Crawley integrates the neurophysiological, behavioral, and release studies which demonstrate both excitatory effects of CCK, and facilitatory modulating effects of CCK on the inhibitory actions of dopamine, in the mesolimbic pathway. Nonpeptide antagonists selective for the CCKA and CCKB receptors have recently been developed, and provide long-awaited tools to test hypotheses about the role of endogenous CCK as a modulator of dopaminergic function, and the potential of CCK-based drugs as treatments for neuropsychiatric disorders.

UR - http://www.scopus.com/inward/record.url?scp=0025828120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025828120&partnerID=8YFLogxK

U2 - 10.1016/0165-6147(91)90558-A

DO - 10.1016/0165-6147(91)90558-A

M3 - Article

C2 - 2048219

AN - SCOPUS:0025828120

VL - 12

SP - 232

EP - 236

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - C

ER -